Status:
COMPLETED
Pre-operative Tamsulosin and Time to Spontaneous Void After Hysterectomy
Lead Sponsor:
University of Arizona
Conditions:
Urinary Retention Postoperative
Eligibility:
FEMALE
18-80 years
Phase:
PHASE2
Brief Summary
The aim of this study is to determine if a one time dose of tamsulosin given pre-operatively decreases the time to void and the time to discharge after minimally invasive hysterectomy.
Eligibility Criteria
Inclusion
- Women 18-80 undergoing outpatient minimally invasive hysterectomy
Exclusion
- Inability to provide informed consent
- Bladder malignancy
- Intra-operative bladder or ureteral injury; anticipated prolonged bladder catheterization
- Plan for sling or anterior repair
Key Trial Info
Start Date :
April 16 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 24 2023
Estimated Enrollment :
161 Patients enrolled
Trial Details
Trial ID
NCT04859660
Start Date
April 16 2021
End Date
June 24 2023
Last Update
February 29 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Banner University Medical Center- Phoenix
Phoenix, Arizona, United States, 85006
2
Banner University Medical Center- Tucson
Tucson, Arizona, United States, 85718